Literature DB >> 9736402

Genetic alterations in primary and secondary hyperparathyroidism.

L Shan1, Y Nakamura, M Nakamura, T Yokoi, K Kakudo.   

Abstract

Hyperparathyroidism refers to a term representing a wide spectrum of parathyroid disorders that are characterized by the increased production of parathyroid hormone. Hyperparathyroidism was once thought to be rare but is now more commonly recognized, affecting 1 in 500 women over 40 years of age. Yet the interpretation of parathyroid pathology is still controversial and confusing. Over the past 10 years, genetic changes (ret and menin genes) involved in the pathogenesis of MEN 2 and MEN 1 have been discovered in succession. Different mutations of the calcium-sensing receptor gene have been identified in neonatal severe hyperparathyroidism and familial hypocalciuric hypercalcemia, respectively. The HRPT 2 gene responsible for the development of hereditary hyperparathyroidism and jaw tumors has been localized on the 1q21-31 locus. Several genetic alterations have also been characterized in primary and secondary hyperparathyroidism. Different genetic alterations appear to involve the development of different types of hyperparathyroidism. These novel advances give us new insights into the pathogenesis of hyperparathyroidism and allow better differentiation between the different types of parathyroid disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736402     DOI: 10.1111/j.1440-1827.1998.tb03952.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Molecular pathways associated with transcriptional alterations in hyperparathyroidism.

Authors:  Fang Lee; Jie-Jen Lee; Woan-Ching Jan; Chih-Jen Wu; Han-Hsiang Chen; Shih-Ping Cheng
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

2.  p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas.

Authors:  Begona Arribas; Eva Cristobal; Jose A. Alcazar; Juan Tardio; Juan C. Matinez-Montero; Jose R. Polo; Rafael Carrion; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality.

Authors:  L Shan; Y Nakamura; M Murakami; M Nakamura; A Naito; K Kawahara; H Utsunomiya; I Mori; K Kakudo
Journal:  Jpn J Cancer Res       Date:  1999-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.